Abstract:Network medicine relies on different types of networks: from the molecular level of protein–protein interactions to gene regulatory network and correlation studies of gene expression. Among network approaches based on the analysis of the topological properties of protein–protein interaction (PPI) networks, we discuss the widespread DIAMOnD (disease module detection) algorithm. Starting from the assumption that PPI networks can be viewed as maps where diseases can be identified with localized perturbation within a specific neighborhood (i.e., disease modules), DIAMOnD performs a systematic analysis of the human PPI network to uncover new disease-associated genes by exploiting the connectivity significance instead of connection density. The past few years have witnessed the increasing interest in understanding the molecular mechanism of post-transcriptional regulation with a special emphasis on non-coding RNAs since they are emerging as key regulators of many cellular processes in both physiological and pathological states. Recent findings show that coding genes are not the only targets that microRNAs interact with. In fact, there is a pool of different RNAs—including long non-coding RNAs (lncRNAs) —competing with each other to attract microRNAs for interactions, thus acting as competing endogenous RNAs (ceRNAs). The framework of regulatory networks provides a powerful tool to gather new insights into ceRNA regulatory mechanisms. Here, we describe a data-driven model recently developed to explore the lncRNA-associated ceRNA activity in breast invasive carcinoma. On the other hand, a very promising example of the co-expression network is the one implemented by the software SWIM (switch miner), which combines topological properties of correlation networks with gene expression data in order to identify a small pool of genes—called switch genes—critically associated with drastic changes in cell phenotype. Here, we describe SWIM tool along with its applications to cancer research and compare its predictions with DIAMOnD disease genes.

Analyzing of Molecular Networks for Human Diseases and Drug Discovery

Protein-protein Interaction Network with Machine Learning Models and Multiomics Data Reveal Potential Neurodegenerative Disease-Related Proteins

Heterogeneous Information Network and Its Application to Human Health and Disease

Protein Interaction Networks: Centrality, Modularity, Dynamics, and Applications

Reconstruction and Application of Protein–Protein Interaction Network

Dynamic protein interaction network construction and applications.

Network based approach to drug discovery: a mini review.

Chapter 14: Automated Mining of Disease-Specific Protein Interaction Networks Based on Biomedical Literature

Network-based Analysis of Complex Diseases.

Characterizing the structure of protein-protein interaction networks

Protein-protein interaction networks as miners of biological discovery

Network-Based Approaches to Explore Complex Biological Systems towards Network Medicine

Identifying network biomarkers based on protein-protein interactions and expression data

Drug Target Protein-Protein Interaction Networks: A Systematic Perspective

Protein–Protein Interface and Disease: Perspective from Biomolecular Networks

Structural Hole Spanner in HumanNet Identifies Disease Gene and Drug Targets

Large-scale Identification of Potential Drug Targets Based on the Topological Features of Human Protein–protein Interaction Network

Connecting the dots: Computational network analysis for disease insight and drug repurposing

Human Pathway-Based Disease Network

Structure-based Protein-Protein Interaction Networks and Drug Design

Recent Advances on the Network Models in Target-based Drug Discovery